GlassScriptPhysician profile
Amber D Savells
NPI 1821232273
$2,698.10
in general payments reported to CMS, 2019-2025
31 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $101 · 2021: $55.56 · 2022: $93.84 · 2023: $562 · 2024: $888 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,586 · Education: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,586.27 |
| Education | $223.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $413.20 | 2019-2025 | Veozah, Myrbetriq |
| Medtronic, INC. | $266.62 | 2022-2024 | Interstim |
| Aspira Women'S Health INC | $265.22 | 2024 | Ova1 |
| Sumitomo Pharma America, INC. | $253.08 | 2023-2025 | Myfembree |
| Abbvie INC. | $168.57 | 2019-2025 | Lo Loestrin Fe |
| Allergan, INC. | $167.86 | 2019 | |
| Biogen, INC. | $139.21 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $130.14 | 2020-2025 | Coolseal Generator, Novasure, Aptima |
| Mayne Pharma Commercial LLC | $110.41 | 2023 | |
| Ethicon US, LLC | $71.76 | 2021-2022 | |
| Inari Medical, INC. | $58.30 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bayer Healthcare Pharmaceuticals INC. | $57.36 | 2019-2025 | |
| Medtronic USA, INC. | $48.15 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $44.95 | 2019-2020 | |
| Amgen INC. | $43.98 | 2019-2024 | Evenity, Prolia |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $42.94 | 2019-2024 | Wegovy |
| Amag Pharmaceuticals, INC. | $40.51 | 2019 | |
| Daiichi Sankyo INC. | $40.31 | 2019-2025 | Injectafer |
| Channel Medsystems, INC. | $39.54 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.64 | 2019 | |
| Organon LLC | $37.04 | 2024 | |
| Pfizer INC. | $36.62 | 2019-2022 | |
| Therapeuticsmd, INC. | $34.49 | 2019 | |
| Coloplast Corp | $34.12 | 2019-2024 | |
| Coopersurgical, INC. | $18.61 | 2024 | Endosee |
| Sage Therapeutics, LLC | $18.49 | 2019 | |
| Gynesonics, INC. | $17.44 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Shire North American Group INC | $17.10 | 2019 | |
| Exeltis, USA INC. | $16.17 | 2024 | Slynd |
| Axonics, INC. | $15.08 | 2023 | Bulkamid |
| Baxter Healthcare | $13.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Savells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.